Newsfile Corp
19 Nov 2026, 22:44 UTC · 47m ago
CSE Bulletin: New Listing - Peptide Development Labs Inc. (PEPT)
Impact · against what's priced in
Peptide Development Labs Inc. (PDL) is transitioning to a public entity via a CSE listing. This introduces immediate liquidity and a public valuation mechanism for a previously private company.
- PDL+0.30
No priced-in read yet
- In context
The approval for listing on the CSE provides the company with public visibility and liquidity for shareholders.
Read from the article alone
- Actual

Top 2 movers · tap to explore




